Strengthen medication safety management in patients with chronic kidney disease
10.3760/cma.j.cn114015-20240402-00215
- VernacularTitle:加强慢性肾脏病患者的用药安全管理
- Author:
Wenjing HOU
1
;
Aiping WEN
1
Author Information
1. 首都医科大学附属北京友谊医院药学部，北京 100050
- Publication Type:Journal Article
- Keywords:
Renal insufficiency;
Evidence-based medicine;
Decision support systems, management;
Medication safety
- From:
Adverse Drug Reactions Journal
2024;26(5):257-260
- CountryChina
- Language:Chinese
-
Abstract:
Chronic kidney disease (CKD) has become a global public health problem. Slowing disease progression is vital in CKD management, and drug therapy is an important part of the treatment for CKD patients. However, the risk for adverse drug event is higher in patients with CKD due to impaired renal function, prolonged disease duration, presence of multimorbidity and polypharmacy. Therefore, it was recommended to promote medication safety in patients with CKD through the following 4 specific strategies: (1) carrying out more studies to improve evidence-based practice for medication in patients with CKD; (2) conducting dose adjustments according to glomerular filtration rate and continuous drug therapy monitoring to a dynamic management of the dose; (3) implementing multidisciplinary care; (4) utilizing appropriate information technology actively.
